Safety and long-term efficacy of sirolimus eluting stent in ST-elevation acute myocardial infarction: The REAL (Registro REgionale AngiopLastiche Emilia-Romagna) registry

Cardiovascular Drugs and Therapy

Volumn 20, Issue 1, 2006, Pages 63-68

  Percoco, Gianfranco ^a,b   Manari, Antonio ^c   Guastaroba, Paolo ^d   Campo, Gianluca ^a,b   Guiducci, Vincenzo ^c   Aurier, Enrico ^e   Sangiorgio, Pietro ^e   Passerini, Francesco ^f   Geraci, Giuseppe ^g   Piovaccari, Giancarlo ^h   Naldi, Monica ^a,b   Saia, Francesco ⁱ   Marzocchi, Antonio ⁱ  

^a UNIVERSITY OF FERRARA   (Italy)

^b IRCCS   (Italy)

^c S MARIA NUOVA HOSPITAL   (Italy)

^d Agenzia Sanitaria Regionale dell'Emilia Romagna   (Italy)

^e MAGGIORE HOSPITAL   (Italy)

^f Ospedale di Piacenza   (Italy)

^g UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^h OSPEDALE DEGLI INFERMI   (Italy)

ⁱ UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Acute myocardial infarction; Clinical outcome; Primary percutaneous coronary intervention; Safety; Sirolimus eluting stent

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; RAPAMYCIN; TICLOPIDINE; TIROFIBAN;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL DIAMETER; CARDIOGENIC SHOCK; CLINICAL EXAMINATION; COMPARATIVE STUDY; DEATH; DIABETES MELLITUS; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; HEART REINFARCTION; HUMAN; IMPLANTATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; REVASCULARIZATION; RISK FACTOR; ST SEGMENT ELEVATION; STENT; TARGET VESSEL REVASCULARIZATION; THROMBOSIS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR DISEASES; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS;

EID: 33646466004     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-006-6753-9     Document Type: Article

References (17)

1. Topol EJ, Neumann FJ, Montalescot G. A preferred reperfusion strategy for acute myocardial infarction. J Am Coll Cardiol 2003;42:1886-1889.
2. Moses JW, Leon MB, Popma JJ, et al. For the SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
3. Schofer J, Schluter M, Gershlick AH, et al. For the E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003;362:1093-1099.
4. Lemos PA, Lee C, Degertekin M, et al. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes. J Am. Coll Cardiol 2003;41:2093-2099.
5. Lemos PA, Saia F, Hofma SH, et al. Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol 2004;43:704-708.
6. Saia F, Lemos PA, Lee CH, et al. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: A clinical and angiographic study. Circulation 2003;108:1927-1929.
7. Valgimigli M, Percoco G, Cicchitelli G, et al. Highdose bolus tirofiban and sirolimus eluting stent versus abciximab and bare metal stent in acute myocardial infarction (STRATEGY) study - protocol design and demography of the first 100 patients. Cardiovasc Drugs Ther 2004;18:225-230.
8. Valgimigli M, Percoco G, Malagutti P, et al. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction. A randomized trial. JAMA 2005;293:2109-2117.
9. Marzocchi A, Piovaccari G, Manari A, et al. Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events. Am J Cardiol 2005;95:1409-1414.
10. TIMI study group. The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med 1985;312:932-936.
11. Weber F, Schneider H, Schwarz C, Holzhausen C, Petzsch M, Nienaber CA. Sirolimus-eluting stents for percutaneous coronary intervention in acute myocardial infarction. Z Kardiol 2004;93:938.
12. Moreno R, Fernandez C, Hernandez R, et al. Drug-eluting stent thrombosis. Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005;45:954-959.
13. Eisenberg MJ, Jamal S. Glycoprotein IIb/IIIa inhibition in the setting of acute ST-segment elevation myocardial infarction. J Am Coll Cardiol 2003;42:1-6.
14. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001;344:1895-1903.
15. Buiatti E, Barchielli A, Marchionni N, et al. Determinants of treatment strategies and survival in acute myocardial infarction: A population-based study in the Florence district, Italy. Eur Heart J 2003;24:1195-1203.
16. Antoniucci D, Rodriguez A, Hempel A, et al. A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction. J Am Coll Cardiol 2003;42:1879-1885.
17. Neumann F-J, Kastrati A, Schmitt C, et al. Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction. J Am Coll Cardiol 2000;35:915-921.